Atlas FDA

DILAPAN-S

FDA premarket approval P840045/S006 · decided 2002-10-25

Approval details

PMA number
P840045
Supplement
S006
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
DILAPAN-S
Generic name
dilator, cervical, synthetic, osmotic, pregnancy termination
Applicant
Medicem Technology S.R.O
Date received
2000-03-31
Decision date
2002-10-25
Days to decision
938 days
Decision code
APPR
Product code
LOB
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Kamenne Zehrovice
Statement
APPROVAL FOR A NEW DEVICE DESIGN AND NEW MANUFACTURING LOCATION. THE DEVICE, AS MODIFIED AND WITH REVISED LABELING, WILL BE MARKETED UNDER THE TRADE NAME DILAPAN-S AND IS INDICATED FOR DILATATION OF THE CERVIX UTERI PRIOR TO TERMINATION OF PREGNANCY UP TO 16 WEEKS GESTATION. A SINGLE DILAPAN-S IS INSERTED INTO THE ENDOCERVICAL CANAL AND MAY REMAIN IN SITU FOR UP TO FOUR HOURS. THE DEVICE WILL BE MANUFACTURED AT A NEW FACILITY LOCATED AT GELMED INTERNATIONAL, IN THE CZECH REPUBLIC AND STERILIZED

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Dilapan-S (K143447)Medicem Technology S.R.O2015-04-17